View Item 

Show simple item record

Prevention of Peritonitis in Peritoneal Dialysis

dc.contributor.authorSegal, Jonathan H.en_US
dc.contributor.authorMessana, Joseph M.en_US
dc.date.accessioned2013-08-02T20:51:53Z
dc.date.available2014-09-02T14:12:53Zen_US
dc.date.issued2013-07en_US
dc.identifier.citationSegal, Jonathan H.; Messana, Joseph M. (2013). "Prevention of Peritonitis in Peritoneal Dialysis." Seminars in Dialysis (4): 494-502. <http://hdl.handle.net/2027.42/99100>en_US
dc.identifier.issn0894-0959en_US
dc.identifier.issn1525-139Xen_US
dc.identifier.urihttps://hdl.handle.net/2027.42/99100
dc.description.abstractReducing the frequency of peritonitis for patients undergoing peritoneal dialysis ( PD ) continues to be a challenge. This review focuses on recent updates in catheter care and other patient factors that influence infection rates. An experienced nursing staff plays an important role in teaching proper PD technique to new patients, but nursing staff must be cognizant of each patient's unique educational needs. Over time, many patients become less adherent to proper dialysis technique, such as washing hands or wearing a mask. This behavior is associated with higher risk of peritonitis and is modifiable with re‐training. Prophylactic antibiotics before PD catheter placement can decrease the infection risk immediately after catheter placement. In addition, some studies suggest that prophylaxis against fungal superinfection after antibiotic exposure is effective in reducing fungal peritonitis, although larger randomized studies are needed before this practice can be recommended for all patients. Over time, exit site and nasal colonization with pathogenic organisms can lead to exit‐site infections and peritonitis. For patients with S taphylococcus aureus colonization, exit‐site prophylaxis with either mupirocin or gentamicin cream reduces clinical infection with this organism. Although there are limited data for support, antibiotic prophylaxis before gastrointestinal, gynecologic, or dental procedures may also help reduce the risk of peritonitis.en_US
dc.publisherWiley Periodicals, Inc.en_US
dc.titlePrevention of Peritonitis in Peritoneal Dialysisen_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelInternal Medicine and Specialtiesen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.identifier.pmid23859192en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/99100/1/sdi12114.pdf
dc.identifier.doi10.1111/sdi.12114en_US
dc.identifier.sourceSeminars in Dialysisen_US
dc.identifier.citedreferenceMiles R, Hawley CM, McDonald SP, Brown FG, Rosman JB, Wiggins KJ, Bannister KM, Johnson DW: Predictors and outcomes of fungal peritonitis in peritoneal dialysis patients. Kidney Int 76: 622 – 628, 2009en_US
dc.identifier.citedreferenceLo WK, Chan CY, Cheng SW, Poon JF, Chan DT, Cheng IK: A prospective randomized control study of oral nystatin prophylaxis for Candida peritonitis complicating continuous ambulatory peritoneal dialysis. Am J Kid Dis 28: 549 – 552, 1996en_US
dc.identifier.citedreferenceRestrepo C, Chacon J, Manjarres G: Fungal peritonitis in peritoneal dialysis patients: successful prophylaxis with fluconazole, as demonstrated by prospective randomized control trial. Perit Dial Int 30: 619 – 625, 2010en_US
dc.identifier.citedreferenceSu CY, Pei J, Lu XH, Tang W, Wang T: Gastrointestinal symptoms predict peritonitis rates in CAPD patients. Clin Nephrol 77: 267 – 274, 2012en_US
dc.identifier.citedreferenceWood CJ, Fleming V, Turnidge J, Thomson N, Atkins RC: Campylobacter peritonitis in continuous ambulatory peritoneal dialysis: report of eight cases and a review of the literature. Am J Kid Dis 19: 257 – 263, 1992en_US
dc.identifier.citedreferenceSchweinburg FB, Seligman AM, Fine J: Transmural migration of intestinal bacteria; a study based on the use of radioactive Escherichia coli. N Engl J Med 242: 747 – 751, 1950en_US
dc.identifier.citedreferenceSingharetnam W, Holley JL: Acute treatment of constipation may lead to transmural migration of bacteria resulting in gram‐negative, polymicrobial, or fungal peritonitis. Perit Dial Int 16: 423 – 425, 1996en_US
dc.identifier.citedreferenceChuang YW, Shu KH, Yu TM, Cheng CH, Chen CH: Hypokalaemia: an independent risk factor of Enterobacteriaceae peritonitis in CAPD patients. Nephrol Dial Transplant 24: 1603 – 1608, 2009en_US
dc.identifier.citedreferenceYip T, Tse KC, Lam MF, Cheng SW, Lui SL, Tang S, Ng M, Chan TM, Lai KN, Lo WK: Colonic diverticulosis as a risk factor for peritonitis in Chinese peritoneal dialysis patients. Perit Dial Int 30: 187 – 191, 2010en_US
dc.identifier.citedreferenceYip T, Tse KC, Lam MF, Cheng SW, Lui SL, Tang S, Ng M, Chan TM, Lai KN, Lo WK: Risks and outcomes of peritonitis after flexible colonoscopy in CAPD patients. Perit Dial Int 27: 560 – 564, 2007en_US
dc.identifier.citedreferenceYap DY, Tse KC, Lam MF, Chan TM, Lai KN: Polymicrobial CAPD peritonitis after hysteroscopy. Perit Dial Int 29: 237 – 238, 2009en_US
dc.identifier.citedreferenceMorimoto S, Kido E, Higashi M, Sumitani N, Takagishi H, Kakimoto S, Someya K, Morita T, Iwasaka T, Suzuki K, Yasui A: Peritonitis after gynecological and gastroscopic examinations in a peritoneal dialysis patient. Clin Nephrol 74: 491 – 492, 2010en_US
dc.identifier.citedreferenceLi PK, Leung CB, Leung AK, Luk WK, Lai KN: Posthysteroscopy fungal peritonitis in a patient on continuous ambulatory peritoneal dialysis. Am J Kid Dis 21: 446 – 448, 1993en_US
dc.identifier.citedreferenceLockhart PB, Brennan MT, Sasser HC, Fox PC, Paster BJ, Bahrani‐Mougeot FK: Bacteremia associated with toothbrushing and dental extraction. Circulation 117: 3118 – 3125, 2008en_US
dc.identifier.citedreferenceFried L, Bernardini J, Piraino B: Iatrogenic peritonitis: the need for prophylaxis. Perit Dial Int 20: 343 – 345, 2000en_US
dc.identifier.citedreferenceKiddy K, Brown PP, Michael J, Adu D: Peritonitis due to Streptococcus viridans in patients receiving continuous ambulatory peritoneal dialysis. Brit Med J 290: 969 – 970, 1985en_US
dc.identifier.citedreferenceDaly CD, Campbell MK, MacLeod AM, Cody DJ, Vale LD, Grant AM, Donaldson C, Wallace SA, Lawrence PD, Khan IH: Do the Y‐set and double‐bag systems reduce the incidence of CAPD peritonitis? A systematic review of randomized controlled trials. Nephrol Dial Transplant 16: 341 – 347, 2001en_US
dc.identifier.citedreferenceBrown MC, Simpson K, Kerssens JJ, Mactier RA: Peritoneal dialysis‐associated peritonitis rates and outcomes in a national cohort are not improving in the post‐millennium (2000–2007). Perit Dial Int 31: 639 – 650, 2011en_US
dc.identifier.citedreferencePiraino B, Bernardini J, Brown E, Figueiredo A, Johnson DW, Lye WC, Price V, Ramalakshmi S, Szeto CC: ISPD position statement on reducing the risks of peritoneal dialysis‐related infections. Perit Dial Int 31: 614 – 630, 2011en_US
dc.identifier.citedreferenceNessim SJ: Prevention of peritoneal dialysis‐related infections. Semin Nephrol 31: 199 – 212, 2011en_US
dc.identifier.citedreferenceChow KM, Szeto CC, Leung CB, Law MC, Li PK: Impact of social factors on patients on peritoneal dialysis. Nephrol Dial Transplant 20: 2504 – 2510, 2005en_US
dc.identifier.citedreferenceMartin LC, Caramori JC, Fernandes N, Divino‐Filho JC, Pecoits‐Filho R, Barretti P: Geographic and educational factors and risk of the first peritonitis episode in Brazilian Peritoneal Dialysis study (BRAZPD) patients. Clin J Am Soc Nephrol 6: 1944 – 1951, 2011en_US
dc.identifier.citedreferenceChow KM, Szeto CC, Law MC, Fun Fung JS, Kam‐Tao Li P: Influence of peritoneal dialysis training nurses' experience on peritonitis rates. Clin J Am Soc Nephrol 2: 647 – 652, 2007en_US
dc.identifier.citedreferenceYang Z, Xu R, Zhuo M, Dong J: Advanced nursing experience is beneficial for lowering the peritonitis rate in patients on peritoneal dialysis. Perit Dial Int 32: 60 – 66, 2012en_US
dc.identifier.citedreferenceRusso R, Manili L, Tiraboschi G, Amar K, De Luca M, Alberghini E, Ghiringhelli P, De Vecchi A, Porri MT, Marinangeli G, Rocca R, Paris V, Ballerini L: Patient re‐training in peritoneal dialysis: why and when it is needed. Kidney Int 103: S127 – 132, 2006en_US
dc.identifier.citedreferenceDong J, Chen Y: Impact of the bag exchange procedure on risk of peritonitis. Perit Dial Int 30: 440 – 447, 2010en_US
dc.identifier.citedreferenceMawar S, Gupta S, Mahajan S: Non‐compliance to the continuous ambulatory peritoneal dialysis procedure increases the risk of peritonitis. Int Urol Nephrol 44: 1243 – 1249, 2012en_US
dc.identifier.citedreferenceFigueiredo AE, Poli de Figueiredo CE, d'Avila DO: Peritonitis prevention in CAPD: to mask or not? Perit Dial Int 20: 354 – 358, 2000en_US
dc.identifier.citedreferenceFiranek C, Guest S: Hand hygiene in peritoneal dialysis. Perit Dial Int 31: 399 – 408, 2011en_US
dc.identifier.citedreferenceMiller TE, Findon G: Touch contamination of connection devices in peritoneal dialysis–a quantitative microbiologic analysis. Perit Dial Int 17: 560 – 567, 1997en_US
dc.identifier.citedreferenceRupp ME, Fitzgerald T, Puumala S, Anderson JR, Craig R, Iwen PC, Jourdan D, Keuchel J, Marion N, Peterson D, Sholtz L, Smith V: Prospective, controlled, cross‐over trial of alcohol‐based hand gel in critical care units. Infect Control Hosp Epidemiol 29: 8 – 15, 2008en_US
dc.identifier.citedreferenceGadola L, Poggi C, Poggio M, Saez L, Ferrari A, Romero J, Fumero S, Ghelfi G, Chifflet L, Borges PL: Using a multidisciplinary training program to reduce peritonitis in peritoneal dialysis patients. Perit Dial Int 33: 38 – 45, 2013en_US
dc.identifier.citedreferenceBordin G, Casati M, Sicolo N, Zuccherato N, Eduati V: Patient education in peritoneal dialysis: an observational study in Italy. J Renal Care 33: 165 – 171, 2007en_US
dc.identifier.citedreferenceOreopoulos DG, Bairdhelfrich G, Khanna R, Lum GM, Matthews R, Paulsen K, Twardowski ZJ, Vas SI: Peritoneal catheters and exit‐site practices – current recommendations. Periton Dialysis Bull 7: 130 – 138, 1987en_US
dc.identifier.citedreferenceBennettjones DN, Martin J, Barratt AJ, Duffy TJ, Naish PF, Aber GM: Prophylactic gentamicin prevents early exit‐site infections and peritonitis in CAPD. Periton Dialysis Int 8: 66 – 66, 1988en_US
dc.identifier.citedreferenceLye WC, Lee EJ, Tan CC: Prophylactic antibiotics in the insertion of Tenckhoff catheters. Scand J Urol Nephrol 26: 177 – 180, 1992en_US
dc.identifier.citedreferenceWikdahl AM, Engman U, Stegmayr BG, Sorenssen JG: One‐dose cefuroxime i.v. and i.p. reduces microbial growth in PD patients after catheter insertion. Nephrol Dial Transplant 12: 157 – 160, 1997en_US
dc.identifier.citedreferenceGadallah MF, Ramdeen G, Mignone J, Patel D, Mitchell L, Tatro S: Role of preoperative antibiotic prophylaxis in preventing postoperative peritonitis in newly placed peritoneal dialysis catheters. Am J Kid Dis 36: 1014 – 1019, 2000en_US
dc.identifier.citedreferenceFigueiredo A, Goh BL, Jenkins S, Johnson DW, Mactier R, Ramalakshmi S, Shrestha B, Struijk D, Wilkie M: Clinical practice guidelines for peritoneal access. Perit Dial Int 30: 424 – 429, 2010en_US
dc.identifier.citedreferencePiraino B, Bernardini J, Sorkin M: The influence of peritoneal catheter exit‐site infections on peritonitis, tunnel infections, and catheter loss in patients on continuous ambulatory peritoneal dialysis. Am J Kid Dis 8: 436 – 440, 1986en_US
dc.identifier.citedreferenceDavies SJ, Ogg CS, Cameron JS, Poston S, Noble WC: Staphylococcus aureus nasal carriage, exit‐site infection and catheter loss in patients treated with continuous ambulatory peritoneal dialysis (CAPD). Perit Dial Int 9: 61 – 64, 1989en_US
dc.identifier.citedreferenceLuzar MA, Coles GA, Faller B, Slingeneyer A, Dah GD, Briat C, Wone C, Knefati Y, Kessler M, Peluso F: Staphylococcus aureus nasal carriage and infection in patients on continuous ambulatory peritoneal dialysis. N Engl J Med 322: 505 – 509, 1990en_US
dc.identifier.citedreferenceSwartz R, Messana J, Starmann B, Weber M, Reynolds J: Preventing Staphylococcus aureus infection during chronic peritoneal dialysis. J Am Soc Nephrol 2: 1085 – 1091, 1991en_US
dc.identifier.citedreferenceAmato D, de Jesus Ventura M, Miranda G, Leanos B, Alcantara G, Hurtado ME, Paniagua R: Staphylococcal peritonitis in continuous ambulatory peritoneal dialysis: colonization with identical strains at exit site, nose, and hands. Am J Kid Dis 37: 43 – 48, 2001en_US
dc.identifier.citedreferencevan Diepen AT, Tomlinson GA, Jassal SV: The association between exit site infection and subsequent peritonitis among peritoneal dialysis patients. Clin J Am Soc Nephrol 7: 1266 – 1271, 2012en_US
dc.identifier.citedreferencePiraino B, Bernardini J, Bender FH: An analysis of methods to prevent peritoneal dialysis catheter infections. Perit Dial Int 28: 437 – 443, 2008en_US
dc.identifier.citedreferenceStrippoli GF, Tong A, Johnson D, Schena FP, Craig JC: Antimicrobial agents to prevent peritonitis in peritoneal dialysis: a systematic review of randomized controlled trials. Am J Kid Dis 44: 591 – 603, 2004en_US
dc.identifier.citedreferenceTacconelli E, Carmeli Y, Aizer A, Ferreira G, Foreman MG, D'Agata EM: Mupirocin prophylaxis to prevent Staphylococcus aureus infection in patients undergoing dialysis: a meta‐analysis. Clin Infect Dis 37: 1629 – 1638, 2003en_US
dc.identifier.citedreferenceXu G, Tu W, Xu C: Mupirocin for preventing exit‐site infection and peritonitis in patients undergoing peritoneal dialysis. Nephrol Dial Transplant 25: 587 – 592, 2010en_US
dc.identifier.citedreferenceMupirocin Study Group: Nasal mupirocin prevents Staphylococcus aureus exit‐site infection during peritoneal dialysis. J Am Soc Nephrol 7: 2403 – 2408, 1996en_US
dc.identifier.citedreferenceBernardini J, Bender F, Florio T, Sloand J, Palmmontalbano L, Fried L, Piraino B: Randomized, double‐blind trial of antibiotic exit site cream for prevention of exit site infection in peritoneal dialysis patients. J Am Soc Nephrol 16: 539 – 545, 2005en_US
dc.identifier.citedreferenceBernardini J, Piraino B, Holley J, Johnston JR, Lutes R: A randomized trial of Staphylococcus aureus prophylaxis in peritoneal dialysis patients: mupirocin calcium ointment 2% applied to the exit site versus cyclic oral rifampin. Am J Kid Dis 27: 695 – 700, 1996en_US
dc.identifier.citedreferenceChu KH, Choy WY, Cheung CC, Fung KS, Tang HL, Lee W, Cheuk A, Yim KF, Chan WH, Tong KL: A prospective study of the efficacy of local application of gentamicin versus mupirocin in the prevention of peritoneal dialysis catheter‐related infections. Perit Dial Int 28: 505 – 508, 2008en_US
dc.identifier.citedreferenceDavenport A: Do topical antibiotics reduce exit site infection rates and peritonitis episodes in peritoneal dialysis patients? The Pan Thames Renal Audit. J Nephrol 25: 819 – 824, 2012en_US
dc.identifier.citedreferenceLim CT, Wong KS, Foo MW: The impact of topical mupirocin on peritoneal dialysis infection in Singapore General Hospital. Nephrol Dial Transplant 20: 2202 – 2206, 2005en_US
dc.identifier.citedreferenceLuzar MA, Brown CB, Balf D, Hill L, Issad B, Monnier B, Moulart J, Sabatier JC, Wauquier JP, Peluso F: Exit‐site care and exit‐site infection in continuous ambulatory peritoneal dialysis (CAPD): results of a randomized multicenter trial. Perit Dial Int 10: 25 – 29, 1990en_US
dc.identifier.citedreferenceMahajan S, Tiwari SC, Kalra V, Bhowmik DM, Agarwal SK, Dash SC, Kumar P: Effect of local mupirocin application on exit‐site infection and peritonitis in an Indian peritoneal dialysis population. Perit Dial Int 25: 473 – 477, 2005en_US
dc.identifier.citedreferenceMcQuillan RF, Chiu E, Nessim S, Lok CE, Roscoe JM, Tam P, Jassal SV: A randomized controlled trial comparing mupirocin and polysporin triple ointments in peritoneal dialysis patients: the MP3 Study. Clin J Am Soc Nephrol 7: 297 – 303, 2012en_US
dc.identifier.citedreferencePierce DA, Williamson JC, Mauck VS, Russell GB, Palavecino E, Burkart JM: The effect on peritoneal dialysis pathogens of changing topical antibiotic prophylaxis. Perit Dial Int 32: 525 – 530, 2012en_US
dc.identifier.citedreferencePiraino B, Bernardini J, Florio T, Fried L: Staphylococcus aureus prophylaxis and trends in gram‐negative infections in peritoneal dialysis patients. Perit Dial Int 23: 456 – 459, 2003en_US
dc.identifier.citedreferenceWong SS, Chu KH, Cheuk A, Tsang WK, Fung SK, Chan HW, Tong MK: Prophylaxis against gram‐positive organisms causing exit‐site infection and peritonitis in continuous ambulatory peritoneal dialysis patients by applying mupirocin ointment at the catheter exit site. Perit Dial Int 23 ( Suppl 2 ): S153 – 158, 2003en_US
dc.identifier.citedreferenceAnnigeri R, Conly J, Vas S, Dedier H, Prakashan KP, Bargman JM, Jassal V, Oreopoulos D: Emergence of mupirocin‐resistant Staphylococcus aureus in chronic peritoneal dialysis patients using mupirocin prophylaxis to prevent exit‐site infection. Perit Dial Int 21: 554 – 559, 2001en_US
dc.identifier.citedreferenceBoelaert JR, De Smedt RA, De Baere YA, Godard CA, Matthys EG, Schurgers ML, Daneels RF, Gordts BZ, Van Landuyt HW: The influence of calcium mupirocin nasal ointment on the incidence of Staphylococcus aureus infections in haemodialysis patients. Nephrol Dial Transplant 4: 278 – 281, 1989en_US
dc.identifier.citedreferenceCookson BD: The emergence of mupirocin resistance: a challenge to infection control and antibiotic prescribing practice. J Antimicrob Chemother 41: 11 – 18, 1998en_US
dc.identifier.citedreferenceMiller MA, Dascal A, Portnoy J, Mendelson J: Development of mupirocin resistance among methicillin‐resistant Staphylococcus aureus after widespread use of nasal mupirocin ointment. Infect Control Hosp Epidemiol 17: 811 – 813, 1996en_US
dc.identifier.citedreferenceUpton A, Lang S, Heffernan H: Mupirocin and Staphylococcus aureus: a recent paradigm of emerging antibiotic resistance. J Antimicrob Chemother 51: 613 – 617, 2003en_US
dc.identifier.citedreferenceVasquez JE, Walker ES, Franzus BW, Overbay BK, Reagan DR, Sarubbi FA: The epidemiology of mupirocin resistance among methicillin‐resistant Staphylococcus aureus at a Veterans' Affairs hospital. Infect Control Hosp Epidemiol 21: 459 – 464, 2000en_US
dc.identifier.citedreferenceZakrzewska‐Bode A, Muytjens HL, Liem KD, Hoogkamp‐Korstanje JA: Mupirocin resistance in coagulase‐negative staphylococci, after topical prophylaxis for the reduction of colonization of central venous catheters. J Hosp Infect 31: 189 – 193, 1995en_US
dc.identifier.citedreferencePerez‐Fontan M, Rosales M, Rodriguez‐Carmona A, Falcon TG, Valdes F: Mupirocin resistance after long‐term use for Staphylococcus aureus colonization in patients undergoing chronic peritoneal dialysis. Am J Kid Dis 39: 337 – 341, 2002en_US
dc.identifier.citedreferenceLobbedez T, Gardam M, Dedier H, Burdzy D, Chu M, Izatt S, Bargman JM, Jassal SV, Vas S, Brunton J, Oreopoulos DG: Routine use of mupirocin at the peritoneal catheter exit site and mupirocin resistance: still low after 7 years. Nephrol Dial Transplant 19: 3140 – 3143, 2004en_US
dc.identifier.citedreferenceCho Y, Badve SV, Hawley CM, McDonald SP, Brown FG, Boudville N, Wiggins KJ, Bannister KM, Clayton P, Johnson DW: Effects of climatic region on peritonitis risk, microbiology, treatment, and outcomes: a multicenter registry study. Perit Dial Int 33: 75 – 85, 2013en_US
dc.identifier.citedreferenceGoldie SJ, Kiernan‐Tridle L, Torres C, Gorban‐Brennan N, Dunne D, Kliger AS, Finkelstein FO: Fungal peritonitis in a large chronic peritoneal dialysis population: a report of 55 episodes. Am J Kid Dis 28: 86 – 91, 1996en_US
dc.identifier.citedreferenceMatuszkiewicz‐Rowinska J: Update on fungal peritonitis and its treatment. Perit Dial Int 29 ( Suppl 2 ): S161 – 165, 2009en_US
dc.identifier.citedreferenceRobitaille P, Merouani A, Clermont MJ, Hebert E: Successful antifungal prophylaxis in chronic peritoneal dialysis: a pediatric experience. Perit Dial Int 15: 77 – 79, 1995en_US
dc.identifier.citedreferenceThodis E, Vas SI, Bargman JM, Singhal M, Chu M, Oreopoulos DG: Nystatin prophylaxis: its inability to prevent fungal peritonitis in patients on continuous ambulatory peritoneal dialysis. Perit Dial Int 18: 583 – 589, 1998en_US
dc.identifier.citedreferenceWong PN, Lo KY, Tong GM, Chan SF, Lo MW, Mak SK, Wong AK: Prevention of fungal peritonitis with nystatin prophylaxis in patients receiving CAPD. Perit Dial Int 27: 531 – 536, 2007en_US
dc.identifier.citedreferenceZaruba K, Peters J, Jungbluth H: Successful prophylaxis for fungal peritonitis in patients on continuous ambulatory peritoneal dialysis: six years' experience. Am J Kid Dis 17: 43 – 46, 1991en_US
dc.identifier.citedreferenceWilliams PF, Moncrieff N, Marriott J: No benefit in using nystatin prophylaxis against fungal peritonitis in peritoneal dialysis patients. Perit Dial Int 20: 352 – 353, 2000en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
sdi12114.pdf
Size:
113.2KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.